Compare TAC & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TAC | NVST |
|---|---|---|
| Founded | 1909 | 2018 |
| Country | Canada | United States |
| Employees | 1350 | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.7B |
| IPO Year | N/A | 2019 |
| Metric | TAC | NVST |
|---|---|---|
| Price | $14.31 | $26.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 13 |
| Target Price | $23.67 | ★ $26.46 |
| AVG Volume (30 Days) | 1.2M | ★ 2.6M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | N/A | ★ 104.31 |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $2,566,500,000.00 |
| Revenue This Year | N/A | $6.67 |
| Revenue Next Year | $6.48 | $3.55 |
| P/E Ratio | ★ N/A | $112.65 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.34 | $18.77 |
| 52 Week High | $17.88 | $30.42 |
| Indicator | TAC | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 60.72 | 52.57 |
| Support Level | $13.37 | $24.21 |
| Resistance Level | $14.77 | $26.63 |
| Average True Range (ATR) | 0.41 | 0.79 |
| MACD | 0.07 | -0.08 |
| Stochastic Oscillator | 64.61 | 31.99 |
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse electrical power generation assets in Canada, the United States, and Western Australia. The company has reportable segments namely, Hydro, Wind & Solar, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.